Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioNTech SE (DE:22UA)
XETRA:22UA
Holding DE:22UA?
Track your performance easily
See the Price Targets and Ratings of:
22UA Analyst Ratings
Strong Buy
12 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
22UA Stock 12 Month Forecast
Average Price Target
€130.74
▲(32.06% Upside)
| Highest Price Target€162.16 | Average Price Target€130.74 | Lowest Price Target€114.74 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Evercore ISI
Upgraded
11/19/24
Goldman Sachs
Reiterated
11/18/24
Morgan Stanley
Reiterated
11/18/24
Berenberg Bank
Initiated
11/18/24
H.C. Wainwright
Reiterated
11/18/24
J.P. Morgan
Reiterated
11/15/24
Bank of America Securities
Reiterated
11/15/24
Canaccord Genuity
Reiterated
11/15/24
Leerink Partners
Assigned
11/15/24
Deutsche Bank
Reiterated
11/12/24
TD Cowen
€115.69
Hold
16.86%
Upside
Assigned
11/05/24
Cautious Outlook on BioNTech SE: Strong Q3 Performance Overshadowed by Uncertain Future in Vaccine Sales and Oncology Pipeline
BMO Capital
€115.69→€119.48
Buy
20.69%
Upside
Reiterated
11/04/24
BioNTech (BNTX) PT Raised to $126 at BMO CapitalBMO Capital analyst Etzer Darout raised the price target on BioNTech (NASDAQ: BNTX) to $126.00 (from $122.00) while maintaining a Outperform rating.
Jefferies
€142.24
Buy
43.68%
Upside
Reiterated
11/04/24
Jefferies Reaffirms Their Buy Rating on BioNTech SE (BNTX)
UBS
€124.22
Hold
25.48%
Upside
Reiterated
10/02/24
UBS Sticks to Its Hold Rating for BioNTech SE (BNTX)
Best Analysts Covering BioNTech SE
Which Analyst Should I Follow If I Want to Buy DE:22UA and Sell After:
1 Month
xxx
Success Rate
5/9 ratings generated profit
Average Return
+4.43%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +4.43% per trade.
3 Months
xxx
Success Rate
6/18 ratings generated profit
Average Return
+1.58%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +1.58% per trade.
1 Year
Success Rate
11/18 ratings generated profit
Average Return
+20.17%
reiterated a buy rating 7 days ago
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +20.17% per trade.
2 Years
xxx
Success Rate
11/18 ratings generated profit
Average Return
+30.99%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 61.11% of your transactions generating a profit, with an average return of +30.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
22UA Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
9
7
4
3
5
Buy
14
13
14
20
32
Hold
16
19
22
20
14
Sell
2
4
3
3
1
Strong Sell
0
0
0
0
0
total
41
43
43
46
52
Each month's total comprises the sum of three months' worth of ratings.
22UA Financial Forecast
22UA Stock Forecast FAQ
What is DE:22UA’s average 12-month price target, according to analysts?
Based on analyst ratings, BioNTech SE’s 12-month average price target is €130.74.
What is DE:22UA’s upside potential, based on the analysts’ average price target?
BioNTech SE has 32.06% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BioNTech SE a Buy, Sell or Hold?
BioNTech SE has a consensus rating of Strong Buy, which is based on 12 buy ratings, 4 hold ratings and 0 sell ratings.
What is BioNTech SE’s share price target?
The average share price target for BioNTech SE is €130.74. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €162.16 ,and the lowest forecast is €114.74. The average share price target represents 32.06% Increase from the current price of €99.
The highest analyst share price target is €162.16 ,and the lowest forecast is €114.74. The average share price target represents 32.06% Increase from the current price of €99.
What do analysts say about BioNTech SE?
BioNTech SE’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of BioNTech SE?
To buy shares of DE:22UA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.